YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Fenofibrate-Induced Rhabdomyolysis in a Patient With Stage 4 Chronic Renal Failure Due To Diabetes Mellitus

dc.authorid Reha, Erkoc/0009-0001-7230-8843
dc.authorscopusid 13105952900
dc.authorscopusid 54382862800
dc.authorscopusid 49461096800
dc.authorscopusid 36165464000
dc.authorscopusid 10242147700
dc.authorscopusid 8409430500
dc.authorwosid Turan Canbaz, Esra/Kxs-1505-2024
dc.authorwosid Begenik, Huseyin/Lkl-8263-2024
dc.contributor.author Soyoral, Yasemin Usul
dc.contributor.author Canbaz, Esra Turan
dc.contributor.author Erdur, Mehmet Fatih
dc.contributor.author Emre, Habib
dc.contributor.author Begenik, Huseyin
dc.contributor.author Erkoc, Reha
dc.date.accessioned 2025-05-10T17:47:58Z
dc.date.available 2025-05-10T17:47:58Z
dc.date.issued 2012
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Soyoral, Yasemin Usul; Erdur, Mehmet Fatih; Emre, Habib; Begenik, Huseyin] Yuzuncu Yil Univ, Dept Nephrol, Van, Turkey; [Canbaz, Esra Turan] Yuzuncu Yil Univ, Dept Internal Med, Van, Turkey; [Erkoc, Reha] Univ Bezmi Alem Vakif, Dept Nephrol, Istanbul, Turkey en_US
dc.description Reha, Erkoc/0009-0001-7230-8843 en_US
dc.description.abstract Rhabdomyolysis is defined as a pathological condition of skeletal muscle cell damage leading to the release of toxic intracellular components into the circulation. Several factors may lead to rhabdomyolysis. Fenofibrate is a fibric acid derivative agent that is used in the treatment of hyperlipidaemia. Although several case reports of rhabdomyolysis have been reported due to the combination of statin and fenofibrate, fenofibrate alone rarely causes rhabdomyolysis. When administering fenofibrate in chronic renal failure, dose should be adjusted. Here, we report a case with fenofibrate-induced rhabdomyolysis in a patient with chronic renal failure. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.endpage 851 en_US
dc.identifier.issn 0030-9982
dc.identifier.issue 8 en_US
dc.identifier.pmid 23862266
dc.identifier.scopus 2-s2.0-84880792346
dc.identifier.scopusquality Q3
dc.identifier.startpage 849 en_US
dc.identifier.uri https://hdl.handle.net/20.500.14720/16926
dc.identifier.volume 62 en_US
dc.identifier.wos WOS:000306049600026
dc.identifier.wosquality Q4
dc.language.iso en en_US
dc.publisher Pakistan Medical Assoc en_US
dc.relation.publicationcategory Diğer en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Fenofibrate en_US
dc.subject Rhabdomyolysis en_US
dc.subject Chronic Renal Failure en_US
dc.title Fenofibrate-Induced Rhabdomyolysis in a Patient With Stage 4 Chronic Renal Failure Due To Diabetes Mellitus en_US
dc.type Editorial en_US

Files